Kangmei Pharma | 600518 - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.01M 175K 2026-03
Avita Medical AUD -10.41M 742K 2025-12
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Genomma Lab Internacional MXN 874.42M 73.81M 2026-03
Hypermarcas BRL 647.2M 26.39M 2025-12
Ionis Pharmaceuticals USD -118M 97M 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
Jiangsu Hengrui CNY 2.56B 302M 2026-03
Kangmei Pharma CNY -10.94M 15.75M 2026-03
Moderna USD -1.39B 531M 2026-03
Organon & Co USD 217M 171M 2025-12
Revvity USD 82.77M 63.06M 2026-03
Sh Fosun Pharma CNY 817.9M 46.25M 2026-03
Tectonic Therapeutic USD -21.52M 374K 2025-12
Viatris USD -20.2M 137.3M 2026-03
Wuxi Apptec CNY 5.11B 435.53M 2026-03
Xeris Pharmaceuticals USD 16.77M 10.04M 2025-12
Zz Pientze Pharmaceu CNY 837.81M 336.48M 2026-03